Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Whole blood microRNA levels associate with glycemic status and correlate with target mRNAs in pathways important to type 2 diabetes.

Mononen N, Lyytikäinen LP, Seppälä I, Mishra PP, Juonala M, Waldenberger M, Klopp N, Illig T, Leiviskä J, Loo BM, Laaksonen R, Oksala N, Kähönen M, Hutri-Kähönen N, Raitakari O, Lehtimäki T, Raitoharju E.

Sci Rep. 2019 Jun 20;9(1):8887. doi: 10.1038/s41598-019-43793-4.

2.

Risk Factors for Early-Onset Ischemic Stroke: A Case-Control Study.

Kivioja R, Pietilä A, Martinez-Majander N, Gordin D, Havulinna AS, Salomaa V, Aarnio K, Curtze S, Leiviskä J, Rodríguez-Pardo J, Surakka I, Kaste M, Tatlisumak T, Putaala J.

J Am Heart Assoc. 2018 Nov 6;7(21):e009774. doi: 10.1161/JAHA.118.009774.

3.

Serum Insulin and Cognitive Performance in Older Adults: A Longitudinal Study.

Hooshmand B, Rusanen M, Ngandu T, Leiviskä J, Sindi S, von Arnim CAF, Falkai P, Soininen H, Tuomilehto J, Kivipelto M.

Am J Med. 2019 Mar;132(3):367-373. doi: 10.1016/j.amjmed.2018.11.013. Epub 2018 Nov 29.

PMID:
30502316
4.

Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns Study.

Raitoharju E, Seppälä I, Lyytikäinen LP, Viikari J, Ala-Korpela M, Soininen P, Kangas AJ, Waldenberger M, Klopp N, Illig T, Leiviskä J, Loo BM, Oksala N, Kähönen M, Hutri-Kähönen N, Laaksonen R, Raitakari O, Lehtimäki T.

Sci Rep. 2016 Dec 5;6:38262. doi: 10.1038/srep38262.

5.

Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer's disease: the National Finnish population study (FINRISK).

Tynkkynen J, Hernesniemi JA, Laatikainen T, Havulinna AS, Sundvall J, Leiviskä J, Salo P, Salomaa V.

Age (Dordr). 2016 Dec;38(5-6):465-473. doi: 10.1007/s11357-016-9950-x. Epub 2016 Sep 23.

6.

Cardiovascular risk factors among Russian, Somali and Kurdish migrants in comparison with the general Finnish population.

Skogberg N, Laatikainen T, Koskinen S, Vartiainen E, Jula A, Leiviskä J, Härkänen T, Koponen P.

Eur J Public Health. 2016 Aug;26(4):667-73. doi: 10.1093/eurpub/ckw041. Epub 2016 Apr 9.

PMID:
27060592
7.

Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.

Mäntylä T, Mantere O, Raij TT, Kieseppä T, Laitinen H, Leiviskä J, Torniainen M, Tuominen L, Vaarala O, Suvisaari J.

PLoS One. 2015 May 13;10(5):e0125112. doi: 10.1371/journal.pone.0125112. eCollection 2015.

8.

[Apolipoprotein A-I and B in laboratory diagnostics of dyslipidemia--what benefits do we gain compared with cholesterol measurements?].

Leiviskä J, Sundvall J, Jauhiainen M, Laatikainen T.

Duodecim. 2014;130(22-23):2331-7. Finnish.

PMID:
25558595
9.

Prevention of diabetes and cardiovascular diseases in occupational health care: feasibility and effectiveness.

Viitasalo K, Hemiö K, Puttonen S, Hyvärinen HK, Leiviskä J, Härmä M, Peltonen M, Lindström J.

Prim Care Diabetes. 2015 Apr;9(2):96-104. doi: 10.1016/j.pcd.2014.07.008. Epub 2014 Aug 13.

PMID:
25128324
10.

Association of serum 25-hydroxyvitamin D with lifestyle factors and metabolic and cardiovascular disease markers: population-based cross-sectional study (FIN-D2D).

Miettinen ME, Kinnunen L, Leiviskä J, Keinänen-Kiukaanniemi S, Korpi-Hyövälti E, Niskanen L, Oksa H, Saaristo T, Tuomilehto J, Vanhala M, Uusitupa M, Peltonen M.

PLoS One. 2014 Jul 7;9(7):e100235. doi: 10.1371/journal.pone.0100235. eCollection 2014.

11.

Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort.

Canetta S, Sourander A, Surcel HM, Hinkka-Yli-Salomäki S, Leiviskä J, Kellendonk C, McKeague IW, Brown AS.

Am J Psychiatry. 2014 Sep;171(9):960-8. doi: 10.1176/appi.ajp.2014.13121579.

12.

Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome: the cardiovascular risk in Young Finns Study.

Raitoharju E, Seppälä I, Oksala N, Lyytikäinen LP, Raitakari O, Viikari J, Ala-Korpela M, Soininen P, Kangas AJ, Waldenberger M, Klopp N, Illig T, Leiviskä J, Loo BM, Hutri-Kähönen N, Kähönen M, Laaksonen R, Lehtimäki T.

Mol Cell Endocrinol. 2014 Jun 25;391(1-2):41-9. doi: 10.1016/j.mce.2014.04.013. Epub 2014 Apr 28.

PMID:
24784704
13.

Associations of the Baltic Sea diet with obesity-related markers of inflammation.

Kanerva N, Loo BM, Eriksson JG, Leiviskä J, Kaartinen NE, Jula A, Männistö S.

Ann Med. 2014 Mar;46(2):90-6. doi: 10.3109/07853890.2013.870020. Epub 2014 Jan 22.

PMID:
24447090
14.

Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based study.

Seppälä J, Koponen H, Kautiainen H, Eriksson JG, Kampman O, Leiviskä J, Männistö S, Mäntyselkä P, Oksa H, Ovaskainen Y, Viikki M, Vanhala M, Seppälä J.

BMC Psychiatry. 2013 May 24;13:145. doi: 10.1186/1471-244X-13-145.

15.

Early growth and postprandial appetite regulatory hormone responses.

Perälä MM, Kajantie E, Valsta LM, Holst JJ, Leiviskä J, Eriksson JG.

Br J Nutr. 2013 Nov 14;110(9):1591-600. doi: 10.1017/S0007114513000950. Epub 2013 Apr 19.

PMID:
23597289
16.

Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.

Raitakari OT, Mäkinen VP, McQueen MJ, Niemi J, Juonala M, Jauhiainen M, Salomaa V, Hannuksela ML, Savolainen MJ, Kesäniemi YA, Kovanen PT, Sundvall J, Solakivi T, Loo BM, Marniemi J, Hernesniemi J, Lehtimäki T, Kähönen M, Peltonen M, Leiviskä J, Jula A, Anand SS, Miller R, Yusuf S, Viikari JS, Ala-Korpela M.

Atherosclerosis. 2013 Jan;226(1):245-51. doi: 10.1016/j.atherosclerosis.2012.10.049. Epub 2012 Nov 2.

PMID:
23159013
17.

What have we learnt about high-density lipoprotein cholesterol measurements during 32 years? Experiences in Finland 1980-2012.

Leiviskä J, Sundvall J, Alfthan G, Tähtelä R, Salomaa V, Jauhiainen M, Vartiainen E.

Clin Chim Acta. 2013 Jan 16;415:118-23. doi: 10.1016/j.cca.2012.10.027. Epub 2012 Oct 18.

PMID:
23085381
18.

Serum lipids modify periodontal infection - C-reactive protein association.

Haro A, Saxlin T, Suominen AL, Ylöstalo P, Leiviskä J, Tervonen T, Knuuttila M.

J Clin Periodontol. 2012 Sep;39(9):817-23. doi: 10.1111/j.1600-051X.2012.01920.x. Epub 2012 Jul 11.

PMID:
22780440
19.

Modifying effects of alcohol on the postprandial glucose and insulin responses in healthy subjects.

Hätönen KA, Virtamo J, Eriksson JG, Perälä MM, Sinkko HK, Leiviskä J, Valsta LM.

Am J Clin Nutr. 2012 Jul;96(1):44-9. doi: 10.3945/ajcn.111.031682. Epub 2012 May 30.

PMID:
22648716
20.

Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy?

Thomas MC, Moran JL, Harjutsalo V, Thorn L, Wadén J, Saraheimo M, Tolonen N, Leiviskä J, Jula A, Forsblom C, Groop PH; FinnDiane Study Group.

Diabetologia. 2012 May;55(5):1505-13. doi: 10.1007/s00125-012-2485-5. Epub 2012 Feb 10.

PMID:
22322918
21.

Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study.

Hooshmand B, Solomon A, Kåreholt I, Rusanen M, Hänninen T, Leiviskä J, Winblad B, Laatikainen T, Soininen H, Kivipelto M.

J Intern Med. 2012 Feb;271(2):204-12. doi: 10.1111/j.1365-2796.2011.02484.x. Epub 2011 Dec 30.

22.

Coffee does not modify postprandial glycaemic and insulinaemic responses induced by carbohydrates.

Hätönen KA, Virtamo J, Eriksson JG, Sinkko HK, Erlund I, Jousilahti P, Leiviskä JM, Valsta LM.

Eur J Nutr. 2012 Oct;51(7):801-6. Epub 2011 Oct 25.

PMID:
22038462
23.

Impact of early growth on postprandial responses in later life.

Perälä MM, Valsta LM, Kajantie E, Leiviskä J, Eriksson JG.

PLoS One. 2011;6(8):e24070. doi: 10.1371/journal.pone.0024070. Epub 2011 Aug 31.

24.

The use of fasting vs. non-fasting triglyceride concentration for estimating the prevalence of high LDL-cholesterol and metabolic syndrome in population surveys.

Sundvall J, Leiviskä J, Laatikainen T, Peltonen M, Salomaa V, Vanhala M, Korpi-Hyövälti E, Lauronen J, Alfthan G.

BMC Med Res Methodol. 2011 May 10;11:63. doi: 10.1186/1471-2288-11-63.

25.

Apolipoprotein A-I, apolipoprotein B, and apolipoprotein B/apolipoprotein A-I ratio: reference intervals compared with values in different pathophysiological conditions from the FINRISK 2007 study.

Leiviskä J, Sundvall J, Alfthan G, Jauhiainen M, Salomaa V.

Clin Chim Acta. 2011 May 12;412(11-12):1146-50. doi: 10.1016/j.cca.2011.03.015. Epub 2011 Mar 17.

PMID:
21419755
26.

Metabonomic, transcriptomic, and genomic variation of a population cohort.

Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, Kumpula LS, Hämäläinen E, Jousilahti P, Kangas AJ, Männistö S, Savolainen MJ, Jula A, Leiviskä J, Palotie A, Salomaa V, Perola M, Ala-Korpela M, Peltonen L.

Mol Syst Biol. 2010 Dec 21;6:441. doi: 10.1038/msb.2010.93.

27.

Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study.

Hooshmand B, Solomon A, Kåreholt I, Leiviskä J, Rusanen M, Ahtiluoto S, Winblad B, Laatikainen T, Soininen H, Kivipelto M.

Neurology. 2010 Oct 19;75(16):1408-14. doi: 10.1212/WNL.0b013e3181f88162.

PMID:
20956786
28.

Role of serum cytokines tumour necrosis factor-alpha and interleukin-6 in the association between body weight and periodontal infection.

Saxlin T, Suominen-Taipale L, Leiviskä J, Jula A, Knuuttila M, Ylöstalo P.

J Clin Periodontol. 2009 Feb;36(2):100-5. doi: 10.1111/j.1600-051X.2008.01350.x.

PMID:
19207884
29.

Systematic error of serum triglyceride measurements during three decades and the effect of fasting on serum triglycerides in population studies.

Sundvall J, Laatikainen T, Hakala S, Leiviskä J, Alfthan G.

Clin Chim Acta. 2008 Nov;397(1-2):55-9. doi: 10.1016/j.cca.2008.07.015. Epub 2008 Jul 18.

PMID:
18687321
30.

Serum cholesterol during 27 years: assessment of systematic error and affecting factors and their role in interpreting population trends.

Sundvall J, Leiviskä J, Alfthan G, Vartiainen E.

Clin Chim Acta. 2007 Mar;378(1-2):93-8. Epub 2006 Dec 12.

PMID:
17169352

Supplemental Content

Loading ...
Support Center